New Oxford Textbook of Psychiatry

Herausgeber: Geddes, John R; Goodwin, Guy M; Andreasen, Nancy C

• Gebundenes Buch

Produktbeschreibung

Over its two editions, The New Oxford Textbook of Psychiatry has come to be regarded as one of the most popular and trusted standard psychiatry texts among psychiatrists and trainees.

Produktdetails

• Oxford Textbook
• Verlag: Oxford University Press
• 3 Revised edition
• Seitenzahl: 1536
• Erscheinungstermin: 9. Juni 2020
• Englisch
• Abmessung: 282mm x 230mm x 60mm
• Gewicht: 3658g
• ISBN-13: 9780198713005
• ISBN-10: 0198713002
• Artikelnr.: 57978286

Autorenporträt

John R. Geddes is Professor of Epidemiological Psychiatry and Head of the Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK. Nancy C. Andreasen is Professor of Psychiatry and Andrew H. Woods Chair of Psychiatry, Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA, USA. Guy M. Goodwin is Senior Research Fellow, Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.

Inhaltsangabe

* Section 1: The subject matter and approach to psychiatry
* 1: Kay Redfield Jamison and Adam Ian Kaplin: The patient's
perspective
* 2: Nicole Votruba, Mirja Koschorke, and Graham Thornicroft: Public
attitudes and the challenge of stigma
* 3: Crick Lund, Dörte Bemme, and Judy Bass: Global mental health
* 4: Pierre Pichot: The history of psychiatry as a medical specialty
* 5: Ilina Singh, Julian Savulescu, and Matthew L. Baum: A new ethics
for 21st century psychiatry
* 6: Hans-Jürgen Möller: Foundations of phenomenology / descriptive
psychopathology
* 7: Darrel A. Regier, David P. Goldberg, Geoffrey M. Reed and Bedirhan
T. Ustun: DSM-5 and ICD-11 classifications
* 8: Charles A. Sanislow, Sarah E. Morris, Jennifer Pacheco, and Bruce
N. Cuthbert: The National Institute of Mental Health Research Domain
Criteria: An alternative framework to guide psychopathology research
* 9: Andrea Cipriani, Stefan Leucht, and John R. Geddes: Application of
research evidence in clinical practice
* 10: Guy M. Goodwin, Joseph Zohar, and David J. Kupfer: A neuroscience
based nomenclature for psychotropic drugs
* Section 2: The scientific basis of psychiatric aetiology and
treatment
* 11: Karl Zilles and Nicola Palomero-Gallagher: Neuroanatomy
* 12: Mark Woolrich, Mark Jenkinson, and Clare Mackay: Neuroimaging
technologies
* 13: Olaf Sporns: The connectome
* 14: Trevor Sharp: Neurotransmitters and signalling
* 15: Juan C. Leza, Javier R. Caso, and Borja García-Bueno:
Psychoneuroimmunology
* 16: Caleb Webber: Functional genomics
* 17: Anna Christina Nobre: Cognitive neuroscience: Principles and
methods
* 18: Verena Heise, Enik? Zsoldos, and Klaus P. Ebmeier: Ageing and the
human brain
* 19: Helen S. Mayberg, Andrea Cowell, and Patricio Riva Posse:
Development of brain stimulation
* 20: Amy Chan and Rob Horne: Adherence to treatment in psychiatry
* Section 3: Intellectual disabilities
* 21: Anthony J. Holland: Core dimensions of intellectual disabilities
* 22: Sally-Ann Cooper: Epidemiology and course of intellectual
disabilities
* 23: Judith L. Rapoport, Dale Zhou, and Kwangmi Ahn: Aetiology of
intellectual disability: General issues and prevention
* 24: José-Luis Ayuso-Mateos and Cary S. Kogan: Management and
treatment of intellectual disability
* Section 4: Autism spectrum disorders
* 25: Fred R. Volkmar and Scott L. J. Jackson: Core dimensions of
autism spectrum disorders
* 26: Emily J. H. Jones: Basic mechanisms and treatment targets for
autism spectrum disorders
* 27: Charles R. Newton: Epidemiology of autism
* 28: Abha R. Gupta, Thomas V. Fernandez, and Ellen J. Hoffman:
Genetics of autism spectrum disorders
* 29: Christine Eckera and Declan Murphy: Imaging of autism spectrum
disorders
* 30: Emily Simonoff: Management and treatment of autism spectrum
disorders
* Section 5: Attention deficit and hyperactivity disorder
* 31: Eric Taylor: Core dimensions of attention deficit hyperactivity
disorder
* 32: Barbara Franke and Jan K. Buitelaar: Basic mechanisms and
treatment planning / targets for attention deficit hyperactivity
disorder
* 33: Guilherme V. Polanczyk: Epidemiology of attention deficit
hyperactivity disorder and the implications for its prevention
* 34: Kate Langley and Anita Thapar: Genetics of attention deficit
hyperactivity disorder
* 35: Philip Shaw and Eszter Szekely: Insights from neuroanatomical
imaging into attention deficit hyperactivity disorder throughout the
lifespan
* 36: Alessandro Zuddas and Sara Carucci: Management and treatment of
attention deficit hyperactivity disorder
* Section 6: Motor disorders
* 37: Davide Martino and Antonella Macerollo: Neurodevelopmental motor
disorders
* Section 7: Delirium, dementia, and other cognitive disorders
* 38: Noel J. Buckley and George K. Tofaris: Pathways of
neurodegeneration underlying dementia
* 39: Ravi S. Bhat and Kenneth Rockwood: Delirium
* 40: Ivan Koychev and John Gallacher: Alzheimer's disease
* 41: Akitoshi Takeda and Bruce Miller: Frontotemporal dementias
* 42: Akin Nihat, TzeHow Mok, and John Collinge: Prion disease
* 43: Anto P. Rajkumar and Dag Aarsland: Dementia with Lewy bodies
* 44: Michele Hu and Fahd Baig: Dementia in Parkinson's disease
* 45: Russell L. Margolis: Dementia due to Huntington's disease
* 46: Joanne A. Byars and Ricardo E. Jorge: Vascular cognitive
impairment
* 47: Christian Lepage, Inga K. Koerte, Vivian Schultz, Michael J.
Coleman, and Martha E. Shenton: Traumatic brain injury
* Section 8: Substance use disorders
* 48: Trevor W. Robbins and Barry J. Everitt: Substance use disorders
and the mechanisms of drug addiction
* 49: Yann Le Strat, Nicolas Ramoz, and Philip Gorwood: Genetics of
substance use disorders
* 50: Wim van den Brink and Falk Kiefer: Alcohol use disorder
* 51: Michael Farrell, Briony Larance, and Courtney Breen: Opiates:
Heroin, methadone, buprenorphine
* 52: David J. Castle: Cannabis and mental illness
* 53: Adam R. Winstock and Remy Flechais: Stimulants, ecstasy, and
other party drugs
* 54: Adam Winstock and James Rucker: Psychedelics and dissociative
substances
* 55: Marcus Munafo and Meryem Grabski: Tobacco addiction
* 56: Julia M. A. Sinclair and Anne Lingford-Hughes: Co-morbidity of
substance use and psychiatric disorders
* Section 9: Schizophrenia and psychotic disorders
* 57: Nancy C. Andreasen: The core dimensions of schizophrenia
* 58: Assen Jablensky: Epidemiology and course of schizophrenia
* 59: Kimberley M. Kendall, James T. R. Walters and Michael C. O
Donovan: Genetics of schizophrenia
* 60: Andreea O. Diaconescu, Sandra Iglesias, and Klaas E. Stephan:
Structural and functional neuroimaging of schizophrenia
* 61: William S. Stone, Stephen V. Faraone and Ming T. Tsuang:
Schizoaffective and schizotypal disorders / acute and transient
psychotic disorders
* 62: Andreas Marneros: Delusional disorders
* 63: Emre Bora, Mahesh Jayaram, and Christos Pantelis: Prevention and
early intervention in psychotic disorders
* 64: Herbert Y. Meltzer and William V. Bobo: Antipsychotic and
anticholinergic drugs
* 65: Joseph P. McEvoy, Kammarauche Asuzu, Daniel W. Bradford, Oliver
Freudenreich, and Katherine Moyer: The treatment and management of
patients with schizophrenia
* Section 10: Mood disorders
* 66: S. Nassir Ghaemi and Sivan Mauer: Diagnosis, classification and
differential diagnosis of mood disorders
* 67: Lars Vedel Kessing: Epidemiology of mood disorders
* 68: Gin S. Malhi: Primary prevention of mood disorders: Building a
target for prevention strategies
* Section 11: Bipolar disorder
* 69: Grant C. Churchill, Nisha Singh, and Michael J. Berridge: Basic
mechanisms of and treatment targets for bipolar disorder
* 70: Francis J. MacMahon and Sevilla Detera-Wadlieigh: Genetics of
bipolar disorder
* 71: Mary L. Phillips and Wayne C. Drevets: Neuroimaging of bipolar
disorder
* 72: Eduard Vieta, Isabella Pacchiarotti, and David J. Miklowitz:
Management and treatment of bipolar disorder
* 73: Ian Jones and Arianna Di Florio: Perinatal psychiatry
* Section 12: Depressive disorders
* 74: Marcela Pereira, Roberto Andreatini, and Per Svenningsson: Basic
mechanisms of and treatment targets for depressive disorders
* 75: Alison K. Merikangas and Kathleen R. Merikangas: Genetic
epidemiology of depression in the molecular era
* 76: Guy M. Goodwin and Michael Browning: Imaging of depressive
disorders
* 77: Philip J. Cowen: Management and treatment of depressive disorders
* Section 13: Trauma and stress or related and adjustment disorders
* 78: Dean G. Kilpatrick, Matthew J. Friedman, and Amanda K. Gilmore:
Classification and descriptive psychopathology of posttraumatic
stress disorder and other stressor-related disorders
* 79: Bruce S. McEwen: Basic mechanisms of and treatment targets for
stress-related disorders
* 80: Michael G. Gottschalk and Katharina Domschke: Genetics of
stress-related disorders
* 81: Navneet Kaur, Cecilia Hinojosa, Julia Russell, Michael B. Van
Elzakker, and Lisa M. Shin: Imaging of stress-related disorders
* 82: Maria Bragesjö, Emily A. Holmes, Filip Arnberg, and Erik M.
Andersson: Primary prevention and epidemiology of trauma and stress
related disorders
* 83: Leigh van den Heuvel and Soraya Seedat: Management and treatment
of stress-related disorders
* 84: Beverley Raphael, Sally Wooding, and Julie Dunsmore: Bereavement
* 85: Deborah Davis and Elizabeth F. Loftus: Recovered memories and
false memories
* Section 14: Anxiety disorders
* 86: Nastassja Koen and Dan J. Stein: Core dimensions of anxiety
disorders
* 87: Martien Kas and Berend Olivier: Basic mechanisms, genetics,
targets and animal models for anxiety disorders
* 88: Hans-Ulrich Wittchen and Katja Beesdo-Baum: Epidemiology and
course of anxiety disorders
* 89: Michael G. Gottschalk and Katharina Domschke: Genetics of anxiety
disorders
* 90: Gregor Leicht and Christoph Mulert: Neuroimaging of anxiety
disorders
* 91: Aliza Werner-Seidler, Jennifer L. Hudson, and Helen Christensen:
The primary prevention of anxiety disorders
* 92: David S. Baldwin and Nathan T. M. Huneke: Treatment of anxiety
disorders
* Section 15: Obsessive-compulsive and related disorders
* 93: Sophie C. Snyder, Eric A. Storch, and Wayne K. Goodman: Core
dimensions of obsessive-compulsive disorder
* 94: Eric Burguière and Luc Mallet: Basic mechanisms of and treatment
/ planning targets for obsessive-complusive disorder
* 95: Lior Carmi, Naomi A. Fineberg, Oded Ben-Arush, and Joseph Zohar:
Obsessive-compulsive disorder
* 96: Gerald Nestadt and Jack Samuels: Genetics of obsessive-compulsive
disorder
* 97: Rebbia Shahab and Emily R. Stern: Imaging of obsessive-compulsive
disorder
* 98: Naomi A. Fineberg, Lynne M. Drummond, Jemma Reid, Eduardo Cinosi,
Lior Carmi, and Davis N. Mpavaenda: Management and treatment of
obsessive-compulsive disorder
* 99: Lorena Fernández de la Cruz and David Mataix-Cols: Hoarding
disorder
* 100: Megan M. Kelly and Katharine A. Phillips: Body dysmorphic
disorder
* Section 16: Feeding and eating disorders
* 101: Chris Fairburn and Rebecca Murphy: The eating disorders
* 102: Johannes Hebebrand, Jochen Antel, and Beate Herpertz-Dahlmann:
Basic mechanisms and potential for treatment of weight and eating
disorders
* 103: Katherine A Halmi: Epidemiology and primary prevention of
feeding and eating disorders
* 104: Christopher Hüble, Cynthia Bulik, and Gerome Breen: Genetics of
feeding and eating disorders
* 105: Natalie Kurniadi, Christina E. Wierenga, Laura A. Berner, and
Walter H. Kaye: Imaging of feeding and eating disorders
* 106: Susan L. McElroy, Anna I. Guerdjikova, Nicole Mori, Paul L.
Houser, and Paul E. Keck, Jr.: Management and treatment of feeding
and eating disorders
* 107: Jamie Hartmann-Boyce, Nerys M. Astbury, and Susan A. Jebb:
Aetiology and management of obesity
* 108: Alexander von Gontard: Elimination disorders in children and
adolescents
* Section 17: Sleep wake disorders
* 109: David Pritchett, Angus S. Fisk, Russell G. Foster, and Stuart N.
Peirson: Basic mechanisms of and treatment targets for sleep-wake
disorders
* 110: Kirstie Anderson: Diagnosis of sleep and circadian rhythm
disorder
* 111: Lena Katharina Keller, Eva C. Winnebeck, and Till Roenneberg:
Epidemiology of sleep-wake and primary prevention of its disorders
* 112: Diego R. Mazzotti, Allan I. Pack, and Philip R. Gehrman:
Genetics of sleep-wake disorders
* 113: Umberto Moretto, Dylan Smith, Liliana Dell Osso, and Thien Thanh
Dang-Vu: Multi-modal imaging of sleep-wake disorders
* 114: Simon D. Kyle, Alasdair L. Henry, and Colin A. Espie: Management
of insomnia and circadian rhythm sleep-wake disorders
* Section 18: Sexual function and sexual dysfunction
* 115: Cynthia A. Graham and John Bancroft: The sexual dysfunctions and
paraphilias
* 116: Els Elaut and Gunter Heylens: Gender dysphoria
* Section 19: Personality disorders
* 117: Andrew E. Skodol and Leslie C. Morey: Core dimensions of
personality pathology
* 118: Kate E. A. Saunders and Steve Pearce: Basic mechanisms of and
treatment planning / targets for personality disorders
* 119: Renato D. Alarcón and Brian A. Palmer: Personality disorders:
Epidemiology and clinical course
* 120: C. Robert Cloninger: Genetics of personality disorders
* 121: Christian Paret and Christian Schmahl: Imaging of personality
disorders
* 122: Giles Newton-Howes and Roger Mulder: Treatment and management of
personality disorder
* Section 20: Impulse control and conduct disorders
* 123: Donald W. Black: Impulse control and its disorders: including
pathological gambling
* 124: Stephen Scott and Melanie Palmer: Conduct disorders and
antisocial personality disorder in childhood and adolescence
* Section 21: Suicide
* 125: Merete Nordentoft, Trine Madsen, and Annette Erlangsen:
Epidemiology and causes of suicide
* 126: Nav Kapur, Sarah Steeg, and Adam Moreton: Self-harm:
Epidemiology and risk factors
* 127: J. John Mann and Dianne Currier: Biological aspects of suicidal
behaviour
* 128: Keith Hawton, Kate E. A. Saunders, and Alexandra Pitman:
Prevention of suicide and treatment following self-harm
* Section 22: Somatic symptoms and related disorders
* 129: Michael Sharpe and Jane Walker: Deconstructing dualism: The
interface between physical and psychological illness
* 130: Chantal Berna and Irene Tracey: Neural mechanisms in chronic
pain relevant for psychiatric interventions
* 131: Jonathan Price: Treatment of fibromyalgia (chronic widespread
pain) and chronic fatigue syndrome
* 132: Thomas Merten and Harald Merckelbach: Factitious disorder and
malingering
* 133: Jon Stone and Michael Sharpe: Functional neurological symptom
disorder (Conversion disorder)
* Section 23: Service provision
* 134: Martin Knapp: Public policy and service needs in mental health
* 135: Tom Burns and Tony Kendrick: Planning and providing mental
health services for a community
* 136: Judit Simon: Health economic analysis of service provision
* 137: William H. Sledge and Julianne Dorset: The organization of
psychiatric services for general hospital departments: Proactive and
preventive interventions in psychiatry
* 138: Mina Fazel, Susan Rees, and Derrick Silove: Refugees and
populations exposed to mass conflict
* Section 24: Forensic psychiatry
* 139: Seena Fazel and Mark Toynbee: Associations between psychiatric
disorder and offending
* 140: Sue Bailey and Prathiba Chitsabesan: Developmental approach to
understanding the needs of young people in contact with the criminal
justice system
* 141: Stephen J. Hucker: Child molesters and other sexual offenders
* 142: Rosemary Purcell and Paul E. Mullen: Stalking and querulous
behaviour
* 143: Louise M. Howard and Deirdre MacManus: Domestic violence and
abuse and mental health
* 144: Alec Buchanan: Assessing and managing the risk of violence
towards others
* 145: John O Grady: The expert witness in the criminal and civil
courts
* 146: Matthew Large and Olav Nielssen: Homicide